In The News, page-26

Imo what EMD desperately needs to do now is a solid placement with as much allocation to Tenmile as possible.

Currently just about 2 Qtrs of cash left. Some R&D cash about to hit. But not enough. Revenue etc yes but also consistently high espenses.

The cash situation makes the market uncertain imo.

Stage 3 study commencement + solid placement news should not be left unaddressed for too long imo.

Won’t be holding my breath for any left field MDMA analogues US partnership announcements prior to the above two points being sorted imo

Absolutely must secure a solid cash balance at this point based on my opinion